The company plans to share longer follow-up data from the study in the future. Sana’s clinical pipeline comprises two other candidates, SC291 and SC262, which are being developed in separate ...
Last week, Sana Biotechnology, a once-mysterious and still-buzzy biotech startup, released clinical trial results showing that it had managed to implant insulin-producing cells in the arm muscle ...
Television actress Sana Makbul is currently basking in the success after winning the title of Bigg Boss OTT season 3. She ...
SEATTLE, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology ... We look forward to longer follow-up and plan to submit study results for publication as well as for presentation at an upcoming ...
clinical and regulatory development plans and timing expectations; the ability of Sana’s HIP platform to generate cells ex vivo that can evade the patient’s immune system to enable the ...